Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could ...

In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...

Aging research has experienced substantial advancements in the past decade, particularly in understanding the interrelation ...

In an exclusive interview, one of UCLA's top scientists spoke out about what the disruptions in funding could mean to you and to science.

Scientists who rely on federal grants for vital research have been left 'panicking' due to the President's threats over funding cuts.

U.S. Rep. Don Beyer of Virginia led 89 of his colleagues in decrying attacks on the NIH that endanger vitally important medical research.

The new Kids First datasets advance our understanding of how genetics contribute to childhood cancers and congenital disorders, opening new doors for prevention and treatment.

Trump’s nomination of Mr. Kennedy for secretary of HHS is a blow to science. Kennedy is an anti-vaccine activist, science ...

Despite litigation, federal officials are moving to cut off funding for efforts to improve the health of transgender people, ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Guo has not only been about software and assay development but also about identifying new drugs and new indications for existing drugs for the treatment of lung cancer and breast cancer. Through the ...